Longboard Pharmaceuticals, Inc.

NASDAQ:LBPH

59.78 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 0000.008000000000000000
Cost of Revenue 00.0020.0010.0010.0010.0020.0010.0010.0010.0020.0010.0010000000
Gross Profit 0-0.002-0.0010.007-0.001-0.002-0.001-0.001-0.001-0.002-0.001-0.0010000000
Gross Profit Ratio 0000.875000000000000000
Reseach & Development Expenses 21.4520.44513.1712.19810.48812.5368.539.1939.4038.9217.1216.3684.0934.9154.3982.1711.6030.80.059
General & Administrative Expenses 6.6745.1984.943.3753.0943.1063.4322.5342.4812.6462.4992.4262.2622.0721.3057.9380.9470.7670.115
Selling & Marketing Expenses 00-0.0010000000000000000
SG&A 6.6745.1984.9393.3753.0943.1063.4322.5342.4812.6462.4992.4262.2622.0721.3057.9380.9470.7670.115
Other Expenses 0-0.047-0.009-0.027-0.014-0.017-0.01-0.0090.0010.033-0.009-0.003-0.013-0.00600000
Operating Expenses 28.12425.64318.10915.57313.58215.64211.96211.72711.88411.5679.628.7946.3556.9875.70310.1092.551.5670.174
Operating Income -28.124-25.643-18.11-15.573-13.582-15.642-11.962-11.727-11.884-11.567-9.62-8.794-6.355-6.987-5.703-10.109-2.55-1.567-0.174
Operating Income Ratio 000-1,946.625000000000000000
Total Other Income Expenses Net 3.5843.8583.1240.540.6480.6430.5060.3820.2880.160.0230.0210.010.0070.0040000
Income Before Tax -24.54-21.785-14.986-15.033-12.934-14.999-11.456-11.345-11.596-11.407-9.597-8.773-6.345-6.98-5.699-10.109-2.55-1.567-0.174
Income Before Tax Ratio 000-1,879.125000000000000000
Income Tax Expense -24.54-0.002-0.042-0.567-0.001-0.66-0.506-0.382-0.288-0.127-0.032-0.025-6.378-7-5.703-10.109-2.55-1.567-0.174
Net Income -24.54-21.785-14.986-15.033-12.934-14.999-10.95-10.963-11.308-11.407-9.597-8.773-6.345-6.98-5.699-10.109-2.55-1.567-0.174
Net Income Ratio 000-1,879.125000000000000000
EPS -0.63-0.56-0.42-0.63-0.55-0.65-0.54-0.64-0.66-0.67-0.56-0.52-0.38-0.41-0.34-0.6-0.15-0.093-0.01
EPS Diluted -0.63-0.56-0.42-0.63-0.55-0.65-0.54-0.64-0.66-0.67-0.56-0.52-0.38-0.41-0.34-0.6-0.15-0.093-0.01
EBITDA -28.124-25.641-18.109-15.572-13.581-15.64-11.961-11.726-11.883-11.565-9.619-8.794-6.355-6.987-5.703-10.1090-1.5670
EBITDA Ratio 000-1,946.5000000000000000